ATM Kinase pp 215-227 | Cite as

Mass Spectrometry-Based Proteomics for Quantifying DNA Damage-Induced Phosphorylation

  • Marina E. Borisova
  • Sebastian A. Wagner
  • Petra Beli
Part of the Methods in Molecular Biology book series (MIMB, volume 1599)


Protein phosphorylation plays central regulatory roles in DNA damage repair and signaling. Protein kinases of the phosphatidylinositol 3-kinase-related kinase family ATM, ATR, and DNA-PKcs mediate phosphorylation of hundreds of substrates after DNA damage and thereby orchestrate the cellular response to DNA damage. Protein phosphorylation can be studied using antibodies that specifically recognize phosphorylated protein species; however, this approach is limited by existing antibodies and does not permit unbiased discovery of phosphorylation sites or analyzing phosphorylation sites in a high-throughput manner. Mass spectrometry (MS)-based proteomics has emerged as a powerful method for identification of phosphorylation sites on individual proteins and proteome-wide. To identify phosphorylation sites, proteins are digested into peptides and phosphopeptides are enriched using titanium dioxide (TiO2)-based chromatography followed by the identification by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Quantitative proteomics approaches, such as stable isotope labeling with amino acids in cell culture (SILAC), enable relative quantification of phosphopeptide abundance in different conditions. Here, we describe a streamlined protocol for enrichment of phosphopeptides using TiO2-based chromatography, and outline the application of quantitative phosphoproteomics for the identification of DNA damage-induced phosphorylation and substrates of kinases functioning after DNA damage.

Key words

ATM ATR DNA damage signaling Mass spectrometry-based proteomics Phosphoproteomics Phosphorylation Protein kinase SILAC TiO2 



The research in PB’s group is supported by the German Research Foundation (Emmy Noether Program, BE 5342/1-1 and SFB 1177 on Selective Autophagy) and the Marie Curie Career Integration Grant from the European Commision (grant agreement number: 630763). The research in SAW’s group is supported by the LOEWE program Ubiquitin Networks (Ub-Net) of the State of Hesse (Germany).


  1. 1.
    Polo SE, Jackson SP (2011) Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev 25:409–433. doi: 10.1101/gad.2021311 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Ciccia A, Elledge SJ (2010) The DNA damage response: making it safe to play with knives. Mol Cell 40:179–204. doi: 10.1016/j.molcel.2010.09.019 CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Beli P, Lukashchuk N, Wagner SA et al (2012) Proteomic investigations reveal a role for RNA processing factor THRAP3 in the DNA damage response. Mol Cell 46:212–225. doi: 10.1016/j.molcel.2012.01.026 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Matsuoka S, Ballif BA, Smogorzewska A et al (2007) ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316:1160–1166. doi: 10.1126/science.1140321 CrossRefPubMedGoogle Scholar
  5. 5.
    Bennetzen MV, Larsen DH, Bunkenborg J et al (2010) Site-specific phosphorylation dynamics of the nuclear proteome during the DNA damage response. Mol Cell Proteomics 9:1314–1323. doi: 10.1074/mcp.M900616-MCP200 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Bensimon A, Schmidt A, Ziv Y et al (2010) ATM-dependent and -independent dynamics of the nuclear phosphoproteome after DNA damage. Sci Signal 3:rs3. doi: 10.1126/scisignal.2001034 CrossRefPubMedGoogle Scholar
  7. 7.
    Stokes MP, Rush J, MacNeill J et al (2007) Profiling of UV-induced ATM/ATR signaling pathways. Proc Natl Acad Sci 104:19855–19860. doi: 10.1073/pnas.0707579104 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Blasius M, Forment JV, Thakkar N et al (2011) A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1. Genome Biol 12:R78. doi: 10.1186/gb-2011-12-8-r78 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Wagner SA, Oehler H, Voigt A et al (2015) ATR inhibition rewires cellular signaling networks induced by replication stress. Proteomics. doi: 10.1002/pmic.201500172 Google Scholar
  10. 10.
    Bensimon A, Aebersold R, Shiloh Y (2011) Beyond ATM: the protein kinase landscape of the DNA damage response. FEBS Lett 585:1625–1639. doi: 10.1016/j.febslet.2011.05.013 CrossRefPubMedGoogle Scholar
  11. 11.
    Larance M, Lamond AI (2015) Multidimensional proteomics for cell biology. Nat Rev Mol Cell Biol 16:269–280. doi: 10.1038/nrm3970 CrossRefPubMedGoogle Scholar
  12. 12.
    Macek B, Mann M, Olsen JV (2009) Global and site-specific quantitative phosphoproteomics: principles and applications. Annu Rev Pharmacol Toxicol 49:199–221. doi: 10.1146/annurev.pharmtox.011008.145606 CrossRefPubMedGoogle Scholar
  13. 13.
    Thingholm TE, Jensen ON, Larsen MR (2009) Analytical strategies for phosphoproteomics. Proteomics 9:1451–1468. doi: 10.1002/pmic.200800454 CrossRefPubMedGoogle Scholar
  14. 14.
    Nita-Lazar A, Saito-Benz H, White FM (2008) Quantitative phosphoproteomics by mass spectrometry: past, present, and future. Proteomics 8:4433–4443. doi: 10.1002/pmic.200800231 CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Rigbolt KTG, Blagoev B (2012) Quantitative phosphoproteomics to characterize signaling networks. Semin Cell Dev Biol 23:863–871. doi: 10.1016/j.semcdb.2012.05.006 CrossRefPubMedGoogle Scholar
  16. 16.
    Engholm-Keller K, Larsen MR (2011) Titanium dioxide as chemo-affinity chromatographic sorbent of biomolecular compounds—applications in acidic modification-specific proteomics. J Proteomics 75:317–328. doi: 10.1016/j.jprot.2011.07.024 CrossRefPubMedGoogle Scholar
  17. 17.
    Zhou H, Low TY, Hennrich ML et al (2011) Enhancing the identification of phosphopeptides from putative basophilic kinase substrates using Ti (IV) based IMAC enrichment. Mol Cell Proteomics 10:M110.006452. doi: 10.1074/mcp.M110.006452 CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Zhou H, Ye M, Dong J et al (2008) Specific phosphopeptide enrichment with immobilized titanium ion affinity chromatography adsorbent for phosphoproteome analysis. J Proteome Res 7:3957–3967. doi: 10.1021/pr800223m CrossRefPubMedGoogle Scholar
  19. 19.
    Imanishi SY, Kochin V, Ferraris SE et al (2007) Reference-facilitated phosphoproteomics: fast and reliable phosphopeptide validation by microLC-ESI-Q-TOF MS/MS. Mol Cell Proteomics 6:1380–1391. doi: 10.1074/mcp.M600480-MCP200 CrossRefPubMedGoogle Scholar
  20. 20.
    McNulty DE, Annan RS (2008) Hydrophilic interaction chromatography reduces the complexity of the phosphoproteome and improves global phosphopeptide isolation and detection. Mol Cell Proteomics 7:971–980. doi: 10.1074/mcp.M700543-MCP200 CrossRefPubMedGoogle Scholar
  21. 21.
    Beausoleil SA, Jedrychowski M, Schwartz D et al (2004) Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc Natl Acad Sci U S A 101:12130–12135. doi: 10.1073/pnas.0404720101 CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Olsen JV, Blagoev B, Gnad F et al (2006) Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127:635–648. doi: 10.1016/j.cell.2006.09.026 CrossRefPubMedGoogle Scholar
  23. 23.
    Gauci S, Helbig AO, Slijper M et al (2009) Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem 81:4493–4501. doi: 10.1021/ac9004309 CrossRefPubMedGoogle Scholar
  24. 24.
    Batth TS, Francavilla C, Olsen JV (2014) Off-line high-pH reversed-phase fractionation for in-depth phosphoproteomics. J Proteome Res 13:6176–6186. doi: 10.1021/pr500893m CrossRefPubMedGoogle Scholar
  25. 25.
    Wiśniewski JR, Nagaraj N, Zougman A et al (2010) Brain phosphoproteome obtained by a FASP-based method reveals plasma membrane protein topology. J Proteome Res 9:3280–3289. doi: 10.1021/pr1002214 CrossRefPubMedGoogle Scholar
  26. 26.
    Nühse TS, Stensballe A, Jensen ON, Peck SC (2003) Large-scale analysis of in vivo phosphorylated membrane proteins by immobilized metal ion affinity chromatography and mass spectrometry. Mol Cell Proteomics 2:1234–1243. doi: 10.1074/mcp.T300006-MCP200 CrossRefPubMedGoogle Scholar
  27. 27.
    Ong S-E, Mann M (2005) Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol 1:252–262. doi: 10.1038/nchembio736 CrossRefPubMedGoogle Scholar
  28. 28.
    Rappsilber J, Mann M, Ishihama Y (2007) Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc 2:1896–1906. doi: 10.1038/nprot.2007.261 CrossRefPubMedGoogle Scholar
  29. 29.
    Weinert BT, Scholz C, Wagner SA et al (2013) Lysine succinylation is a frequently occurring modification in prokaryotes and eukaryotes and extensively overlaps with acetylation. Cell Rep 4:842–851. doi: 10.1016/j.celrep.2013.07.024 CrossRefPubMedGoogle Scholar
  30. 30.
    Wiśniewski JR, Zougman A, Mann M (2009) Combination of FASP and StageTip-based fractionation allows in-depth analysis of the hippocampal membrane proteome. J Proteome Res 8:5674–5678. doi: 10.1021/pr900748n CrossRefPubMedGoogle Scholar
  31. 31.
    Ishihama Y, Rappsilber J, Andersen JS, Mann M (2002) Microcolumns with self-assembled particle frits for proteomics. J Chromatogr A 979:233–239CrossRefPubMedGoogle Scholar
  32. 32.
    Michalski A, Damoc E, Hauschild JP et al (2011) Mass spectrometry-based proteomics using Q Exactive, a high-performance benchtop quadrupole Orbitrap mass spectrometer. Mol Cell Proteomics 10(M111):011015. doi: 10.1074/mcp.M111.011015 PubMedGoogle Scholar
  33. 33.
    Kelstrup CD, Young C, Lavallee R et al (2012) Optimized fast and sensitive acquisition methods for shotgun proteomics on a quadrupole orbitrap mass spectrometer. J Proteome Res 11:3487–3497. doi: 10.1021/pr3000249 CrossRefPubMedGoogle Scholar
  34. 34.
    Olsen JV, Macek B, Lange O et al (2007) Higher-energy C-trap dissociation for peptide modification analysis. Nat Methods 4:709–712. doi: 10.1038/nmeth1060 CrossRefPubMedGoogle Scholar
  35. 35.
    Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26:1367–1372. doi: 10.1038/nbt.1511 CrossRefPubMedGoogle Scholar
  36. 36.
    Tyanova S, Mann M, Cox J (2014) MaxQuant for in-depth analysis of large SILAC datasets. Methods Mol Biol 1188:351–364. doi: 10.1007/978-1-4939-1142-4_24 CrossRefPubMedGoogle Scholar
  37. 37.
    Cox J, Neuhauser N, Michalski A et al (2011) Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res 10:1794–1805. doi: 10.1021/pr101065j CrossRefPubMedGoogle Scholar
  38. 38.
    Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article3. doi: 10.2202/1544-6115.1027 PubMedGoogle Scholar
  39. 39.
    Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98:5116–5121. doi: 10.1073/pnas.091062498 CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Bendall SC, Hughes C, Stewart MH et al (2008) Prevention of amino acid conversion in SILAC experiments with embryonic stem cells. Mol Cell Proteomics 7:1587–1597. doi: 10.1074/mcp.M800113-MCP200 CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Cox J, Matic I, Hilger M et al (2009) A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics. Nat Protoc 4:698–705. doi: 10.1038/nprot.2009.36 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2017

Authors and Affiliations

  • Marina E. Borisova
    • 1
  • Sebastian A. Wagner
    • 2
  • Petra Beli
    • 1
  1. 1.Institute of Molecular Biology (IMB)MainzGermany
  2. 2.Department of Medicine, Hematology/OncologyGoethe UniversityFrankfurtGermany

Personalised recommendations